Biomarkers for Lupus Nephritis
Authors:
- Brad H. RovinBRBrad H. Rovin
- Xiaolan ZhangXZXiaolan Zhang
- 1 November 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 4 (11) , 1858-1865
Abstract
Current treatment of severe lupus nephritis is unsatisfactory in terms of both outcome and toxicity. To improve the efficacy and decrease the adverse effects of immunosuppression, it would be ideal to be able to predict the course and pathology of lupus nephritis and adjust therapy appropriately. This will require biomarkers that reflect disease activity. Recently, significant effort has been put into identifying biomarkers that can anticipate impending lupus renal flare, forecast development of chronic kidney disease, or reflect kidney histology at the time of flare. Although these biomarkers are potentially useful, to date none has been clinically validated in a large, prospective cohort of patients with SLE. This article reviews the current status of lupus nephritis biomarker investigation and articulates a perspective of how future efforts should be focused.Keywords
This publication has 57 references indexed in Scilit:
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus NephritisJournal of the American Society of Nephrology, 2009
- Initial Validation of a Novel Protein Biomarker Panel for Active Pediatric Lupus NephritisPediatric Research, 2009
- Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritisRheumatology, 2008
- Biomarkers of lupus nephritis determined by serial urine proteomicsKidney International, 2008
- Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac SurgeryClinical Journal of the American Society of Nephrology, 2008
- Identification of a urinary proteomic signature for lupus nephritis in childrenPediatric Nephrology, 2007
- Urine Biomarkers Predict the Cause of Glomerular DiseaseJournal of the American Society of Nephrology, 2007
- Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus ErythematosusPLOS Medicine, 2006
- Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus ? relationship with disease activity and renal involvementClinical Rheumatology, 2003
- The Endothelial Cell Protein C Receptor (EPCR) Functions as a Primary Receptor for Protein C Activation on Endothelial Cells in Arteries, Veins, and CapillariesBiochemical and Biophysical Research Communications, 1999